Synairgen plc (LON:SNG – Get Free Report)’s stock price dropped 5.2% during mid-day trading on Thursday . The stock traded as low as GBX 3.50 ($0.04) and last traded at GBX 3.93 ($0.05). Approximately 339,001 shares changed hands during trading, an increase of 7% from the average daily volume of 316,664 shares. The stock had previously closed at GBX 4.15 ($0.05).
Synairgen Trading Down 46.6 %
The stock has a market cap of £4.03 million, a PE ratio of -66.67 and a beta of -2.23. The company has a quick ratio of 6.35, a current ratio of 6.77 and a debt-to-equity ratio of 0.09. The firm has a 50-day simple moving average of GBX 4.46 and a 200-day simple moving average of GBX 4.42.
About Synairgen
Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of COVID-19; inhaled interferon beta (IFN-ß), which is in Phase-II clinical trials for the treatment of asthma caused by the common cold and flu; and IFN-ß that is in Phase-II clinical trials for the treatment or prevention of chronic obstructive pulmonary disease.
See Also
- Five stocks we like better than Synairgen
- Basic Materials Stocks Investing
- Oil Titans Face Off: Exxon Mobil or Chevron for 2025 Gains?
- How to invest in marijuana stocks in 7 steps
- Mining Stocks Back in the Spotlight: 3 Key Names to Watch
- Investing in the High PE Growth Stocks
- MarketBeat Week in Review – 12/16 – 12/20
Receive News & Ratings for Synairgen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synairgen and related companies with MarketBeat.com's FREE daily email newsletter.
